Zevaskyn is applied as genetically engineered skin grafts to treat chronic wounds in RDEB patients. Credit: Eder Paisan via ...

The Janus kinase inhibitor was developed by scientists at AbbVie. Credit: © AbbVie Inc. All rights reserved. The US Food and ...

AstraZeneca is migrating into the final phases of a possible Covid-19 vaccine. Credit: Shutterstock AstraZeneca has ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

US President Donald Trump mentioned the possibility of potential tariffs on foreign-made pharmaceuticals. This threat was ...

Companies are developing myostatin inhibitors for GLP-1RA-related muscle loss, but some experts question their necessity.

Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s ...

Prilenia has signed a partnership and licence agreement with Ferrer for jointly developing and commercialising pridopidine in ...

The EC has granted conditional marketing approval to Regeneron Pharmaceuticals’ bispecific antibody Lynozyfic for treating ...